|
Name |
Aspulvinone E
|
Molecular Formula | C17H12O5 | |
IUPAC Name* |
(5Z)-4-hydroxy-3-(4-hydroxyphenyl)-5-[(4-hydroxyphenyl)methylidene]furan-2-one
|
|
SMILES |
C1=CC(=CC=C1/C=C\2/C(=C(C(=O)O2)C3=CC=C(C=C3)O)O)O
|
|
InChI |
InChI=1S/C17H12O5/c18-12-5-1-10(2-6-12)9-14-16(20)15(17(21)22-14)11-3-7-13(19)8-4-11/h1-9,18-20H/b14-9-
|
|
InChIKey |
BNNVVTQUWNGKPH-ZROIWOOFSA-N
|
|
Synonyms |
Aspulvinone E; 49637-60-7; Aspergillide B1; CHEBI:17704; G24NR54FG4; (5Z)-4-Hydroxy-3-(4-hydroxyphenyl)-5-((4-hydroxyphenyl)methylene)-2(5H)-furanone; (5Z)-4-Hydroxy-3-(4-hydroxyphenyl)-5-[(4-hydroxyphenyl)methylene]-2(5H)-furanone; 2(5H)-Furanone, 4-hydroxy-3-(4-hydroxyphenyl)-5-((4-hydroxyphenyl)methylene)-, (5Z)-; C02006; UNII-G24NR54FG4; 4-hydroxy-5-(4-hydroxybenzylidene)-3-(4-hydroxyphenyl)furan-2(5H)-one; CHEMBL2337339; DTXSID201317721; BDBM50453556; ZINC30724298; ZINC136143039; CCG-208773; NCGC00183583-01; NCGC00183583-02; Q27102544; (5Z)-4-hydroxy-3-(4-hydroxyphenyl)-5-[(4-hydroxyphenyl)methylidene]furan-2(5H)-one; (5Z)-4-hydroxy-5-(4-hydroxybenzylidene)-3-(4-hydroxyphenyl)furan-2(5H)-one
|
|
CAS | 49637-60-7 | |
PubChem CID | 54675753 | |
ChEMBL ID | CHEMBL2337339 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 296.27 | ALogp: | 2.6 |
HBD: | 3 | HBA: | 5 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 87.0 | Aromatic Rings: | 3 |
Heavy Atoms: | 22 | QED Weighted: | 0.734 |
Caco-2 Permeability: | -4.886 | MDCK Permeability: | 0.00001940 |
Pgp-inhibitor: | 0.102 | Pgp-substrate: | 0.005 |
Human Intestinal Absorption (HIA): | 0.007 | 20% Bioavailability (F20%): | 0.95 |
30% Bioavailability (F30%): | 0.088 |
Blood-Brain-Barrier Penetration (BBB): | 0.043 | Plasma Protein Binding (PPB): | 92.62% |
Volume Distribution (VD): | 0.378 | Fu: | 15.58% |
CYP1A2-inhibitor: | 0.689 | CYP1A2-substrate: | 0.086 |
CYP2C19-inhibitor: | 0.727 | CYP2C19-substrate: | 0.063 |
CYP2C9-inhibitor: | 0.607 | CYP2C9-substrate: | 0.953 |
CYP2D6-inhibitor: | 0.105 | CYP2D6-substrate: | 0.376 |
CYP3A4-inhibitor: | 0.765 | CYP3A4-substrate: | 0.244 |
Clearance (CL): | 7.047 | Half-life (T1/2): | 0.764 |
hERG Blockers: | 0.032 | Human Hepatotoxicity (H-HT): | 0.141 |
Drug-inuced Liver Injury (DILI): | 0.711 | AMES Toxicity: | 0.137 |
Rat Oral Acute Toxicity: | 0.373 | Maximum Recommended Daily Dose: | 0.194 |
Skin Sensitization: | 0.585 | Carcinogencity: | 0.243 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.125 |
Respiratory Toxicity: | 0.149 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003373 | 0.726 | D09ZQN | 0.388 | ||||
ENC005410 | 0.697 | D00LFB | 0.375 | ||||
ENC003492 | 0.598 | D0Y2NE | 0.372 | ||||
ENC005411 | 0.576 | D03UOT | 0.355 | ||||
ENC000822 | 0.561 | D06TJJ | 0.354 | ||||
ENC002571 | 0.506 | D01XBA | 0.309 | ||||
ENC001576 | 0.468 | D05VLS | 0.305 | ||||
ENC005038 | 0.466 | D04AIT | 0.304 | ||||
ENC002755 | 0.466 | D0J7RK | 0.292 | ||||
ENC000826 | 0.451 | D0JY8T | 0.291 |